IGHE and primary hypertrophic osteoarthropathy: Seroepidemiological studies comparing Norway and Sweden, at the time of study representing high-PHO-consuming and non- PHO-consuming countries, respectively, have shown that in Norway, 6% of blood donors and 11% of those with allergy were IgE sensitized to PHO, whereas in Sweden, not one single sensitized individual was found [5].